Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Screening for ligands of human retinoid X receptor-alpha using ultrafiltration mass spectrometry.
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus.
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.
See All 41 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.
Sands BE, Schreiber S, Lirio RA. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply. N Engl J Med. 2020 01 02; 382(1):93-94.
View in:
PubMed
subject areas
Adalimumab
Antibodies, Monoclonal, Humanized
Colitis, Ulcerative
Humans
Infliximab